Background: The single nucleotide polymorphism (SNP) context of a previously identified periodontitisassociated locus is investigated, and its association with microbial, biologic, and periodontal disease clinical parameters is examined.
P eriodontal disease is the polygenic condition of tooth-supporting structures. [1] [2] [3] [4] Early studies in monozygotic and dizygotic twins showed that 33% to 48% of variance in periodontal disease expression was attributable to genetics. 1, 5 Notably, alterations in genes encoding proteins involved in the immune response are shown to influence host microbiota and increase periodontal clinical parameters of disease. Individuals with variants in interleukin (IL)-1a, IL-1b, and IL-6 are shown to have a unique periodontal microbiome with high levels of classic ''red'' and ''orange'' complex species that are known to be significantly associated with periodontal inflammation. 6 IL-6 polymorphisms have also been moderately associated with diagnosis of periodontitis. 7 In addition, individuals with single gene mutations of b2 integrins leading to leukocyte adhesion deficiency-1 show increased bacterial loads, decreased complexity of biofilms, and severe periodontal bone loss. 8 Together, evidence supports the concept that genetic alterations controlling the immune response of the host can lead to alterations of microbial communities and predispose individuals to periodontal disease.
Genome-wide association studies (GWASs) and candidate gene studies have been used in an attempt to identify single nucleotide polymorphisms (SNPs) that either contribute to the pathogenesis and/or risk of developing periodontal disease. To date, four studies [9] [10] [11] [12] have conducted GWAS analysis to identify SNPs associated with the American Academy of Periodontology (AAP) definition of chronic periodontal disease. 13 No single marker met the genome-wide significance criteria, although the following four loci met gene-centric statistical significance criteria: 1) ninein (NIN); 2) abhydrolase domain containing 12B (ABD12B); 3) WAS protein homolog associated with actin, golgi membranes, and microtubules (WHAMM); and 4) adaptorrelated protein complex-3 b-2 subunit (AP3B2). 11 Therefore, a new approach was used to identify SNPs that were relevant to the pathogenesis of periodontal disease. This approach used a combination of the levels of eight classic periodontal pathogens and gingival crevicular fluid (GCF)-IL-1b to derive periodontal complex traits (PCTs) via principal component analysis. 14 The objective of this approach was to identify loci related to the biologic background and pathogenesis of periodontal disease. Approximately 2.5 million markers were evaluated among 975 European American adults. Several traits were derived by this analysis, with each trait having different eigenvalues (loadings) of the eight microorganisms and GCF-IL-1b. PCT1 (named the Socransky Trait) was defined by a microbial community structure with high positive loadings of all periodontal pathogens and correlated with clinical measurements of periodontal disease. 15 Six loci were associated with PCT1: 1) CType Lectin Domain Family 19 Member A (CLEC19A); 2) T-Cell Receptor a Locus (TRA); 3) Glycoprotein, a-Galactosyltransferase 2, Pseudogene (GGTA2P); 4) Transmembrane 9 Superfamily Member 2 (TM9SF2); 5) RNA Binding Motif Single Stranded Interacting Protein 3 (RBMS3); and 6) interferon (IFN)g-inducible protein 16 (IFI16)/absent in melanoma (AIM)2. 14 Clinical, microbial, and biologic characterization of individuals with SNP variants in these six individual loci is currently unknown. This present study further investigates IFI16/ AIM2 loci using bioinformatics and clinical, microbial, and biologic data.
Both IFI16 and AIM2 are members of the IFN-inducible PYHIN protein family that contain C-terminal DNAbinding hematopoietic expression, IFN-inducible nature, and nuclear localization (HIN) domain(s) and an N-terminal Pyrin domain that belongs to the death domain superfamily of signaling molecules. 16, 17 Both IFI16 and AIM2 are intracellular recognition sensors that trigger inflammatory responses against DNA from host and microorganisms. 17 Increased expression of AIM2 has been reported in a number of inflammatory diseases, including psoriasis, atopic dermatitis, venous ulcers, inflammatory disease, and periodontitis, suggesting involvement with inflammation. [18] [19] [20] [21] [22] Expression of IFI16 in inflammatory diseases has been less explored, but increased expression is reported in inflammatory bowel disease. 22 To the best knowledge of the authors, no study has explored expression of IFI16 in periodontal tissues. Because of the critical role of these proteins in innate immunity, the purpose of this study is to evaluate the relationship between SNPs in the IFI16 and AIM2 loci with periodontal microorganisms, levels of GCF-IL-1b, and clinical parameters of periodontal disease. Meanwhile, descriptive analysis of IFI16 and AIM2 protein expression in gingival samples derived from healthy individuals and individuals with periodontal disease showed expression in multiple cells, including inflammatory cells. Conclusively, a previous study by the authors 14 and the present study support that variants in IFI16/AIM2 are associated with increased loads of periodontal pathogens and increased parameters of clinical disease.
MATERIALS AND METHODS

GWAS Population
A total of 4,766 Northern European descendants (2,264 males and 2,502 females, aged 53 to 74 years; mean age: 62.8 years) were enrolled in the Dental Atherosclerosis Risk in Communities (DARIC) cohort as described elsewhere. 23, 24 Blood was collected as described for genotyping for 2.5 million markers. 9 GCF was collected at four gingival sampling areas from the mesio-buccal region of each first molar from each individual and stored for further analysis of IL-1b levels. 23 Plaque samples were collected from the subgingival mesio-buccal site of the maxillary right first molar and stored for further DNA whole chromosomal checkerboard for the eight periodontal pathogens. Periodontal measurements (n = 4,766) in all teeth at six sites per tooth were collected and included number of missing teeth, gingival index, plaque index (PI), probing depths (PD), clinical attachment level (CAL), and bleeding on probing (BOP). All sites were examined by trained and calibrated examiners with >90% agreement.
Bioinformatic Approaches
Initial analyses of genome-wide imputed SNP data were done with a software package. 25 The results of that analysis revealed one genome-wide significant SNP in the IFI16 region (lead SNP rs1633266). Markers were identified and visualized in linkage disequilibrium with this polymorphism. 14, 26 Criteria used to prioritize and select SNPs of interest for this analysis were: 1) a statistical significance criterion (P <5 · 10 -5 considered as ''suggestive'' evidence of association); 2) biologic plausibility of genes in the region; 3) functional significance; and 4) linkage disequilibrium, the nonrandom association in the occurrence of alleles at two loci, represented by the square of the correlation coefficient between two indicator variables (r 2 ). SNPs with suggestive association (P <5 · 10 -5 ) with PCT1 were selected and carried forward for screening of missense SNPs with predicted functional protein damage. [27] [28] [29] Using these criteria, two SNPs of interest were identified, rs6940 and rs1057028 located in the IFI16 region. A search and evaluation was made of SNPs in perfect linkage disequilibrium (Northern and Western European ancestry panel, r 2 = 1, D9 = 1 cutoff) with these two markers as previously described. 30 Protein information was gathered, and alignment of the different IFI16 isoforms [clustal 0 (1.1.1) multiple sequence alignment] was performed. 31 SNPs within these loci were carried forward to tests of association with clinical and biologic parameters, including plaque microorganisms, GCF-IL-1b levels, periodontal clinical measurements, and biofilm-gingival interface (BGI)-periodontal disease classification. 32 BGI classification was selected because it defines biologic phenotypes based on eight periodontal pathogens, serum immunoglobulin G (17 bacteria), 16 GCF mediators, PD, and BOP, representing the current disease activity and inflammatory condition of the individual. Previous GWAS studies from the study group of the authors have already shown that traditional American Academy of Periodontlogy (AAP)/American Dental Association (ADA) periodontal disease classification, 13 which uses CAL, a measurement of loss of tissue or history of disease, does not allow identification of groups with similar biologic characteristics. 9, 14 Plaque Microbial Analysis A subset of 909 participants of the DARIC cohort was evaluated for plaque microbial composition using DNA-DNA checkerboard as previously described. 32 One plaque sample was used from each individual and assayed by DNA checkerboard for the eight periodontal pathogens. Microorganism levels were expressed as counts using known microbial standards for Porphyromonas gingivalis (Pg), Prevotella intermedia (Pi), Treponema denticola (Td), Tannerella forsythia (Tf), Campylobacter rectus (Cr), Fusobacterium nucleatum (Fn), Aggregatibacter actinomycetemcomitans (Aa), and Prevotella nigrescens (Pn). Total counts reflect a sum of these targeted pathogens for each individual.
GCF-IL-1b Levels
Four GCF strips were eluted and analyzed separately for each individual (n = 4,407). IL-1b levels were evaluated by enzyme-linked immune-absorbent assay according to instructions provided by the manufacturer, as previously described. 33 GCF analyte concentration data were pooled to provide a mean value for each individual in nanograms per milliliter.
Sample Collection for Immunohistochemistry
To describe tissue distribution of IFI16 and AIM2 in human gingival tissues, gingival biopsies were taken from two individuals with healthy periodontium and two with chronic periodontal disease according to AAP/ADA classification. 13 All participants enrolled in this study provided written informed consent, which was approved by the Institutional Review Board of the University of North Carolina at Chapel Hill, Chapel Hill, NC. Major exclusion criteria included: 1) symptoms of any systemic disease; 2) antibiotic use within 1 month prior to the examination; or 3) medical treatment for any known disease associated with periodontal disease within the last 3 months. Gingival biopsies were harvested either during routine periodontal flap surgeries from participants clinically diagnosed with chronic periodontitis (CP) or crown lengthening surgeries in healthy volunteers. A tissue biopsy sample (3 · 4 mm) was removed from underneath the papillae, buccally or lingually, to include the col area of depth of the osseous crest. On removal, gingival tissues were fixed in 10% neutral-buffered formalin overnight, dehydrated (70% alcohol), and embedded in paraffin for the immunohistochemical procedure.
Immunohistochemistry
Gingival tissue sections (5 mm thick) were obtained in the sagittal direction, including the epithelial and connective tissues. Slides were stained with rabbit polyclonal antiIFI16** and rabbit polyclonal anti-AIM2. † † Antirabbit horseradish peroxidase (HRP)-3,39-diaminobenzidine staining ‡ ‡ was used according to instructions provided by the manufacturer, and slides were counterstained with hematoxylin. Photo images were captured using a microscope. § §
Statistical Analyses
General linear models ii were used to examine associations among SNPs of interest and adjusted mean counts of microorganisms, GCF-IL-1b levels, and clinical measurements, adjusting for microbial plaque levels (P £0.05). x 2 tests were used to examine SNP associations with periodontal disease category (BGI classification) (P £0.05). 32 
RESULTS
SNP Identification and Analysis
A sample of 4,766 Northern European descendants were genotyped and evaluated as PCTs, with PCT1 associated with periodontal clinical parameters of disease. 14 To select correlation of variants with clinical parameters, SNP prioritization was based upon statistical significance, linkage disequilibrium (r 2 ), biologic relevance, gene proximity, coding sequences, and functional prediction. IFI16 rs1633266, an intron variant, was the lead SNP most significantly associated with the Socransky Trait (P = 3.1 · 10 -8 , see Table 1 in online Journal of Periodontology). Analysis indicated the existence of two tight haplotype blocks in perfect linkage disequilibrium (r 2 = 1 and D9 = 1), including IFI16 rs6940 (missense) with neighboring gene AIM2 rs2793845 and several additional intronic SNPs, whereas the second block identified by missense rs1057028 included rs1057027 and additional introns, all located in the IFI16 region (Table 1) . 30 Bioinformatic analysis of functional damages potentially caused by missense SNPs demonstrated that rs6940 (T >S) affected all four isoforms with a prediction of possibly damaging (score: 0.584 to 0.782), rs1057027 as benign, and rs1057028 (Y > N) as probably damaging to the protein function of isoform 3 (score: 0.995) (see supplementary in online Journal of Periodontology). However, rs6940 is located between HIN200-1/p53 C-terminal binding and HIN200-2/p53 core domain binding and could be interfering with the three-dimensional structure and protein function. It is possible that not all four isoforms of IFI16 are affected to the same degree based on different protein sizes (see supplementary Fig. 2C in online Journal of Periodontology). Indeed, rs1057028 is predicted to probably damage isoform 3 only (see supplementary Table 2 in online Journal of Periodontology). Imputation quality was 0.9994 and 0.9999 for rs6940 and rs1057028, respectively. In sum, the present analysis identified two tight haplotype blocks with several SNPs in the IFI16/AIM2 region that are potentially important in the pathogenesis of periodontal disease. SNPs rs6940 and rs1057028 are predicted to be potentially/probably damaging to the protein function.
IFI16 SNPs Are Associated With Parameters of Periodontal Disease
Correlation analysis of the clinical parameters showed that both haplotype blocks rs6940 and rs1057028 had a significant increase in percent sites with extent bleeding on probing (EBOP), and rs1057028 also had a significantly higher percentage of extent of PD ‡4 mm (EPDGE4) ( Table 2 ). Increased trends were observed for mean PD and percent of extent of gingival score ‡1 (EGIGE1) ( Table 2 ). This suggests that SNPs in the region of IFI16 and AIM2 affect the biology of the tissues, leading to an increase in the extent of periodontal disease. Further analysis of the microbiologic composition of plaque samples shows that several periodontal pathogen counts (plaque-adjusted) were also significantly higher in both haplotype blocks, including Pg, Tf, and Cr. Loads of Pg were more than 274 times higher for rs6940 and 90 times higher for rs1057028 comparing 2.2 individuals (homozygous for the minor allele) to 1.1 individuals (homozygous for the major allele). Additional organisms were significantly increased in rs1057028, including Fn and Aa, with similar trends observed for rs1057028 homozygous minor alleles (Table 3 ). This finding further supports that SNPs in the IFI16 and AIM2 ‡ ‡ R&D Systems, Minneapolis, MN.
§ § NY.
ii v9.4, SAS Institute, Cary, NC.
region potentially affect the biologic host response of the individual, leading to increased numbers of periodontal pathogens present in plaque samples. Cytokine analysis showed that individuals with haplotype block rs6940 had a four-fold increased concentration in levels of GCF-IL-1b, with a trend of significance for rs1057028 of two-fold increase (Table 4) . Because IL-1b is a well-known proinflammatory cytokine implicated in periodontal disease progression, 34 the finding of increased levels of this cytokine in the GCF in the presence of SNPs in the IFI16 and AIM2 regions suggest that potential defects in IFI16/AIM2 can alter the inflammatory response of an individual and further influence disease status. Individuals with both haplotype blocks showed an increased percentage of severe periodontal disease (BGI P3) compared with healthy controls (Table 5) , reaching statistical significance for haplotype block rs1057028 (P = 0.02). BGI classification accounts for PD and BOP (and not CAL), representing the current disease activity and inflammation of the individual. Because the presence of SNPs in the IFI16 and AIM2 regions lead to an increase in number of individuals with periodontal disease/inflammation, it suggests that the functional defect increased predisposition of the individual developing the multifactorial condition of periodontal disease. Taken together, the data suggest that the presence of these SNPs alters the normal host response, leading to an increased predisposition to develop periodontal disease, observed by higher numbers of periodontal microorganisms, increased measurements of periodontal disease, and higher number of individuals with clinical disease.
Descriptive Histologic Distribution of IFI16 and AIM2 in Gingival Tissues
The purpose of this approach was to describe IFI16 and AIM2 protein expression in cells of the periodontium. Immunohistochemistry analysis was performed in gingival tissue samples of individuals with healthy tissues (n = 2) (Figs. 1A through 1I) and chronic periodontal disease (n = 2) (Figs. 1J through 1R). Demographics of this population are shown in supplementary Table 3 rs861318  167  Intronic  rs1633256  168  Intronic  rs1772415  389  Intronic  rs856057  654  Intronic  rs856056  680  Intronic  rs856055  796  Intronic  rs856054  868  Intronic  rs856053  885  Intronic  rs1417804  1,594  Intronic  rs1614182  2,137  Intronic  rs1633262  2,499  Intronic  rs1772408  3,260  Intronic  rs1633265  3,338  Intronic  rs2570916  10,257  Intronic  rs855865 25,989 59 upstream
Linkage disequilibrium with lead SNP: Utah residents (CEPH) with Northern and Western European ancestry (CEU) D9 = 1, r 2 = 1.
DISCUSSION
The present study characterized clinical and biologic periodontal data among a sizeable group of participants and examined their association with SNPs in the IFI16/AIM2 locus. Two haplotype blocks were found, one including a missense SNP rs6940 and a variant close to neighboring gene AIM2 and a second block including missense SNP rs1057028, that were significantly associated with periodontal disease parameters, including increased extent PD and BOP, increased GCF-IL-1b levels, higher loads of periodontal pathogens, and higher prevalence of severe periodontal disease. Prediction analysis indicated that the function of IFI16 is altered by the presence of rs6940 and rs1057028. Several additional SNPs were in perfect linkage disequilibrium with the index SNPs. These polymorphisms are quite common in the general population with minor allele frequencies of 0.22 for rs6940 (minor allele: T) and 0.3 for rs1057028 (minor allele: T). It was identified that IFI16 and AIM2 are expressed in epithelial cells, fibroblasts, endothelial cells, and leukocytes of gingival tissues. Presence of these proteins in inflammatory cells of gingival tissues, including the finding of neutrophils in the epithelial layer (Figs. 1K and 1N ) suggests a role of IFI16 and AIM2 in the response to periodontal pathogens. Taken together, these findings propose that these proteins and specific polymorphisms may have an important role in periodontal disease pathogenesis. Previous GWAS analysis by the current group of authors has highlighted loci potentially associated with clinically derived-disease definitions, like chronic periodontal disease, 9, 11 and high levels of specific periodontal pathogens. 35 However, no single marker met the strict genome-wide significance. Only four loci met gene-centric statistical significance. 11 This suggested the existence of several distinct conditions with different genetic and biologic backgrounds with similar overlapping clinical presentations of periodontal tissue loss. Therefore, a new approach was used by defining the disease phenotype as complex traits as previously described. 14, 36 With this approach, six PCTs were identified by levels of eight periodontal pathogens, local inflammatory response (GCF-IL-1b), and clinical data. 14 PCT1 was defined by a uniformly high periodontal pathogen load and significantly correlated with clinical periodontal disease parameters. Six loci were associated with PCT1, which included IFI16/AIM2. Although there was a degree of anticipation that the IFI16/AIM2 haplotype blocks would be correlated with some periodontal microorganisms since the lead SNP was identified from an analysis that used a microbial community structure, individual microorganisms correlated with the haplotype blocks were not known. In addition, clinical measurements and disease significance in this population and tissue distribution of IFI16 and AIM2 were further characterized. Therefore, the present study further refines findings derived from the PCT1 analysis and defines the clinical and biologic characteristics of individuals with SNPs in the IFI16/ AIM2 region. Both IFI16 and AIM2 are PYHIN inflammasome proteins and mediators of innate immune responses. 17 Inflammasomes are multiprotein oligomers that promote activation of inflammatory cytokines IL-1b and IL-18. 37 PYHIN inflammasome proteins bind microbial DNA and form caspase-1-activating inflammasomes (AIM2) or drive type I IFN gene transcription (IFI16). 17 IFI16 is also a mediator of the AIM2 inflammasomedependent pathway by directly binding to AIM2. 38 Therefore, IFI16 has shown anti-inflammatory effects and AIM2 proinflammatory effects. This suggests that defects in expression or protein function of IFI16 could dampen the anti-inflammatory response and thereby increase the proinflammatory response. Studies show that AIM2 is increased in wound healing and in several inflammatory conditions, including psoriasis, atopic dermatitis, and venous ulcers. 18, 19 Additional support for the role of AIM2 and IFI16 in inflammation is a recent demonstration of a strong increase of both proteins in the mucosa of individuals with active inflammatory bowel disease. 22 In accordance with the present findings, three studies have previously demonstrated the presence of AIM2 in gingival tissues. 20, 21, 39 AIM2 expression was increased in gingival tissues from individuals with CP compared with healthy controls and generalized aggressive periodontitis (AgP). In addition, Pg infection can activate the AIM2 inflammasome in vitro. 39 These findings further support an importance of AIM2 in the pathogenesis of periodontal disease. To the best knowledge of the authors, no other study has evaluated expression of IFI16 in periodontal tissues. Further analysis and quantification of this protein in periodontal cells and tissues in various disease states is warranted.
The concept that the host genotype can influence microbiota and lead to disease has been reported previously. Counts of periodontal pathogens from the red and orange complex are reported to be significantly higher at PD >6 mm in IL-1 genotype-positive individuals compared with genotype-negative individuals. 6 IL-6 polymorphisms and haplotypes have also been associated with periodontitis, possibly due to the transcription of IL-6, which alters tissue levels. 7, 40 An alteration in the immune response observed in leukocyte adhesion deficiency also leads to significant changes in the subgingival flora and severe periodontitis. 8 These results are in support of the current data and the concept that changes in the innate immune functions can alter the host response and facilitate development of diseases. A recent study found that IFI16 rs6940 (also identified in this study) and AIM2 rs855873 (also upstream of AIM2) were associated with increased susceptibility to Behc xet disease, a systemic immune-mediated disease characterized by vasculitis and recurrent mucosal ulcerations. 41 The study shows rs6940 decreases expression of anti-inflammatory IFI16 and increases susceptibility to an immune-mediated disease. 41 The fact that Behc xet is associated with epithelial ulceration and the present results show associations of these SNPs with BOP suggests that these variants may impair innate immune responses that maintain epithelial integrity at mucosal surfaces. In fact, individuals with Behc xet disease have increased periodontal disease severity compared with healthy controls, suggesting both diseases share pathogenic aspects. 42, 43 These findings support the hypothesis of a role of anti-inflammatory IFI16 in periodontal disease pathogenesis and that variants of this gene predispose individuals for an altered immune response to infection that ultimately leads to disease. Functional analysis was done to help identify SNPs that have a high potential of altering protein function. The current analysis indicates that both missense SNPs rs6940 and rs1057028 are not localized in the known PYRIN, HIN-200, or p53-binding domains. However, predictions suggest that protein function is potentially/probably altered. Because rs1057028 is localized between both HIN domains it is possible that the variant induces a three-dimensional conformation change to the protein structure. SNP rs6940 is predicted to alter only isoform 3, which is probably related to the different sizes of the isoforms. A previous study suggests that instead of protein function, SNP IFI16 rs6940 decreases expression of IFI16. 41 It is possible that additional SNPs in high linkage disequilibrium with rs6940 are leading to this effect. However, no functional assays were performed in the study. 41 Because the SNP associated with AIM2 is not present in a missense region, predictions for potential alterations could not be performed. Future studies defining the impact of SNPs present in the two haplotype blocks in protein expression and host response should provide additional evidence for the pathogenesis of periodontitis.
Although a biologically relevant region associated with elevated periodontitis parameters was identified, the present results have limitations. Validity of the reported SNP associations will need to be further examined and replicated in a new study. However, it is important to note that identification of these genes was not based on traditional AAP/ADA classification for CP and AgP, which is used in other GWASs. 10, [44] [45] [46] Instead, these genes were first identified in the context of a PCT that used a combination of microorganisms and GCF-IL-1b levels. 14 In this model, periodontal disease is a group of distinct biologic conditions with overlapping clinical presentations. Therefore, future GWAS analysis may consider periodontal complex traits for identifying biologically relevant genes.
CONCLUSIONS
Together, the present results support a role of for IFI16/AIM2 in the pathogenesis of periodontal disease. This association was observed by correlation of SNP variants with increased measurements of microorganisms in the subgingival plaque, increased levels of GCF-IL-1b, increased periodontal clinical parameters of disease, and increased prevalence of severe disease.
